跳至主要内容
临床试验/EUCTR2021-003670-31-BE
EUCTR2021-003670-31-BE进行中(未招募)1 期

Impact of Model-Informed Precision Dosing of Vancomycin in Adults: A randomized, controlled clinical trial

Ghent University Hospital0 个研究点目标入组 180 人开始时间: 2021年8月9日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • - age: =18 years
  • - admitted to the participating ward units (non-critically ill patients)
  • - suspected or confirmed Gram positive infection
  • - planned to start or started on intravenous continuous infusion (CI) vancomycin treatment (if the patient was previously treated with vancomycin, the minimum interval to a previous vancomycin treatment episode is 48 hours)
  • - informed consent signed by the patient or legal representatives
  • - not previously enrolled in this trial
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 107
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 73

排除标准

  • - extracorporeal treatment at inclusion (extracorporeal membrane oxygenation, dialysis, body cooling)
  • - serum creatinine level above 2.5 mg/dL at inclusion
  • - patient death is deemed imminent and inevitable

研究者

相似试验

Study on the impact of precision dosing of... | 临床试验